Campbell, CA, United States of America

Petrus W Roelvink

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Mind of Petrus W. Roelvink

Introduction

Petrus W. Roelvink is a notable inventor based in Campbell, California, who has made significant contributions in the field of genetic therapies. With a total of seven patents to his name, Roelvink has focused on pioneering techniques that utilize RNA interference (RNAi) to address various diseases and disorders. His innovative approaches have the potential to transform treatments in molecular biology.

Latest Patents

Among his latest patents, Roelvink has developed compositions and methods for RNAi expression constructs. This invention provides solutions for expressing RNAi agents against specific genes, whether in vitro or in vivo, aimed at treating various ailments effectively. Another noteworthy patent pertains to multiple-promoter expression cassettes for the simultaneous delivery of RNAi agents, specifically tailored for mammalian cells. These advancements not only highlight Roelvink's ingenuity but also his commitment to enhancing therapeutic regimes through innovative scientific research.

Career Highlights

Petrus W. Roelvink currently works at Benitec, Inc., a company at the forefront of genetic therapies. His career has reflected a dedication to improving the lives of patients through cutting-edge biotechnological innovations. With seven patents registered, he stands as a significant figure in his field, continuously striving to refine methods of intervention in the genetic landscape.

Collaborations

Throughout his career, Roelvink has collaborated with esteemed professionals in the industry, including David A. Suhy and Alexander A. Kolykhalov. These collaborations have played a crucial role in the development of his patents and have further enriched his research endeavors.

Conclusion

Petrus W. Roelvink exemplifies the spirit of innovation within the biotech community. His work, particularly in RNAi technology, promises to usher in new treatment possibilities that could significantly impact patient care and medical research. As he continues his work at Benitec, Inc., the contributions of this inventive mind are sure to pave the way for future breakthroughs in genetic therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…